GSK

Showing 15 posts of 760 posts found.

Pharma companies look to Apple’s ResearchKit for R&D

July 13, 2015
Medical Communications Apple, GSK, Purdue Pharma, R&D, clinical trials, digital health, iOS, iphone, patient engagement, researchkit

Pharma companies are moving into a new area in drug R&D, by using Apple’s ResearchKit platform to gather data from …

Pfizer acquires meningitis vaccines from GSK

June 23, 2015
Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, Pfizer, meningitis

Pharma giants GSK and Pfizer have announced an agreement to transfer the ownership of two meningitis vaccines from GlaxoSmithKline to …

GSK image

GSK ploughs $95m into research institute

June 17, 2015
Research and Development, Sales and Marketing GSK, Pfizer, acquisition, altius, merger, takeover

GlaxoSmithKline is pouring $95 million into a new US research institute to investigate how a cell’s operating system works in …

GSK image

GSK investigator freed from Chinese prison

June 10, 2015
Medical Communications, Sales and Marketing China, GSK, GlaxoSmithKline, brett wells, bribery, scandal

British private investigator Peter Humphrey who worked for GlaxoSmithKline has been released from a Chinese jail following his conviction last …

Perrigo image

Perrigo buys OTC products from GSK

June 3, 2015
Sales and Marketing GSK, GlaxoSmithKline, Mylan, Perrigo, Teva, brett wells

In an all-cash move with no financial details disclosed Perrigo is buying a portfolio of leading over-the-counter products from GlaxoSmithKline. …

paolo_paoletti

Former GSK Oncology president joins Kesios

June 1, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, kesios

The Imperial Innovations Group has confirmed the appointment of Dr Paolo Paoletti to be the executive chairman of Kesios Therapeutics.Paoletti …

Another Chinese health official arrested for corruption

May 27, 2015
Medical Communications, Sales and Marketing China, GSK, bribery, huang fenping, wang yu

A Chinese health official has been arrested on accusations of bribery as the country continues to crack down on corruption …

Novartis image

Novartis reveals ASCO plans

May 27, 2015
Sales and Marketing ASCO, GSK, Novartis

Novartis’ first ASCO conference since buying GlaxoSmithKline’s oncology business will be showcasing drugs from the acquisition. The two firms swapped …

elyse_seltzer

GSK head joins Nabriva as chief medical officer

May 26, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Elyse Seltzer, GSK, Nabriva Therapeutics

Austrian-based clinical stage biopharma firm Nabriva Therapeutics has appointed Dr Elyse Seltzer as its chief medical officer. Seltzer assumes the role …

Analysts predict Pfizer to swallow GSK

May 21, 2015
Sales and Marketing AZ, GSK, GlaxoSmithKline, Pfizer, merger

GlaxoSmithKline has been suggested as a potential M&A target for Pfizer, despite the US company backing out of a similar …

GSK image

GSK launches new HIV research centre

May 11, 2015
Research and Development, Sales and Marketing AIDS, GSK, HIV, UNC-Chapel Hill, ViiV, qura

GlaxoSmithKline is boosting its philanthropic efforts in R&D into HIV/AIDS by teaming up with academic researchers to launch a new …

ViiV founder Dr Manuel Goncalves

Reputation gains from focussing on the patient

May 11, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HIV, Manuel Goncalves, Pfizer, ViiV

Since being spun-off from GSK and Pfizer, specialist HIV firm ViiV Healthcare has earned the best corporate reputation amongst patients …

GSk image

Boardroom shuffles at GSK and Roche

May 8, 2015
Medical Communications, Sales and Marketing GSK, Novartis, Roche, ViiV, changes, leadership

GlaxoSmithKline and Roche have announced the latest changes to its leadership teams as the companies regroup for the year ahead. …

GSK image

Generics continue to erode GSK sales

May 6, 2015
Sales and Marketing GSK, HIV, Novartis, Q1, ViiV, Witty, hampton, respiratory

GlaxoSmithKline’s pharma sales continued to slide in the first quarter of 2015, but ViiV healthcare and the portfolios acquired from …

GSK image

GSK files ultra-rare disease application with EMA

May 6, 2015
Research and Development, Sales and Marketing EMA, GSK, GSK2696273, Wiskott-Aldrich syndrome, bubble boy, metachromatic leukodystrophy

GlaxoSmithKline has become the first big pharma firm to file for a European marketing authorisation for a gene therapy to …

The Gateway to Local Adoption Series

Latest content